Funding for this research was provided by:
defense advanced research projects agency (NCT03412604)
beth israel deaconess medical center (NCT03290326)
Received: 14 July 2021
Accepted: 20 October 2021
First Online: 20 December 2021
: All participants gave written informed consent prior to participating in the studies, registered separately on ExternalRef removed (NCT03412604, NCT03290326; PI Santarnecchi). The research proposal and associated methodologies were approved by the local ethics committee (Beth Israel Deaconess Medical Center IRB) in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: DCA is the inventor of the pseudo-continuous ASL technique employed for perfusion MRI in this work. He receives post-market royalties through his institution from licenses to GE Healthcare, Philips Healthcare, Hitachi Medical, Siemens Healthineers, and UIH America. GR is co-founder of Neuroelectrics and RS is an employer. ES and APL are listed co-inventors on an issued patent on the use of tACS in AD. All other authors declare they have no competing interests.